Firdapse 10 MG
Ended Awarded
- Contract number
- 36C24526N0322
- Awardee
-
Catalyst Pharmaceuticals, Inc. UEI J1B2ARLKWN53
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $19,549
Award facts
- Contract value 100% obligated
- $19,549.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a $19,549.38 firm fixed-price delivery order to Catalyst Pharmaceuticals, Inc. for the supply of Firdapse 10 mg tablets. The contract, awarded on February 12, 2026, with an ultimate completion date of February 16, 2026, was issued without a set-aside designation. Performance will be conducted at the contractor's facility in Bartlett, Tennessee. This delivery order is placed against Catalyst Pharmaceuticals' existing $5.5 million Blanket Purchase Agreement with the Veterans Health Administration National Acquisition Center, established under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and effective through July 25, 2026.
Catalyst Pharmaceuticals, a for-profit pharmaceutical company headquartered in Coral Gables, Florida, specializes in rare disease therapies and has established itself as a primary supplier of Firdapse to the VA system. Firdapse (amifampridine) is an FDA-approved treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune neuromuscular disorder. The contractor's federal portfolio demonstrates sustained engagement with the VA across multiple delivery orders since 2021, totaling approximately $854,000 in combined ceiling values. The BPA structure enables multiple Veterans Integrated Service Networks to place individual delivery orders, streamlining procurement and ensuring consistent product availability across the VA healthcare system while maintaining compliance with statutory pricing requirements through annual public law updates.
Quick answers
Who was awarded contract 36C24526N0322?
36C24526N0322 was awarded to Catalyst Pharmaceuticals, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 12, 2026.
How much is contract 36C24526N0322 worth?
The government has obligated $19,549 on 36C24526N0322.
Is contract 36C24526N0322 an order under another contract?
Yes. 36C24526N0322 is a delivery order under 36F79719D0160, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0322 competed?
The extent of competition for 36C24526N0322 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award